Holger Neb

Frankfurt Am Main, HE 60590, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Think sepsis, write sepsis, code sepsis - patient characteristics associated with sepsis (under-)coding in administrative health data.

Think sepsis, write sepsis, code sepsis - patient characteristics associated with sepsis (under-)coding in administrative health data.

Journal: Infection

Published: May 19, 2025

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection.

Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection.

Journal: ImmunoTargets and therapy

Published: February 09, 2024

EVIDENCE FROM FATAL COVID-19 FOR TARGETING THE BRADYKININ METABOLISM-A SINGLE-CENTER COHORT STUDY.

EVIDENCE FROM FATAL COVID-19 FOR TARGETING THE BRADYKININ METABOLISM-A SINGLE-CENTER COHORT STUDY.

Journal: Shock (Augusta, Ga.)

Published: October 25, 2023

Predicting Survival for Veno-Arterial ECMO Using Conditional Inference Trees-A Multicenter Study.

Predicting Survival for Veno-Arterial ECMO Using Conditional Inference Trees-A Multicenter Study.

Journal: Journal of clinical medicine

Published: August 17, 2023

Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions.

Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions.

Journal: Frontiers in immunology

Published: January 20, 2023

HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY?

HIGH HEPARANASE LEVEL IN SURVIVORS OF COVID-19 - INDICATOR OF VASCULAR AND PULMONARY RECOVERY?

Journal: Shock (Augusta, Ga.)

Published: December 22, 2022

Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study.

Intravenous IgM-enriched immunoglobulins in critical COVID-19: a multicentre propensity-weighted cohort study.

Journal: Critical care (London, England)

Published: April 22, 2022

Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit.

Persistently Elevated Plasma Concentrations of RIPK3, MLKL, HMGB1, and RIPK1 in Patients with COVID-19 in the Intensive Care Unit.

Journal: American journal of respiratory cell and molecular biology

Published: April 06, 2022

Detailed stratified GWAS analysis for severe COVID-19 in four European populations.

Detailed stratified GWAS analysis for severe COVID-19 in four European populations.

Journal: Human molecular genetics

Published: January 14, 2022

Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

Journal: Immunity

Published: October 12, 2020

Lung Ultrasound Findings in Patients with COVID-19.

Lung Ultrasound Findings in Patients with COVID-19.

Journal: SN comprehensive clinical medicine

Published: September 24, 2020

Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.

Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.

Journal: Critical care (London, England)

Published: June 22, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026